SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-029668
Filing Date
2018-11-26
Accepted
2018-11-26 20:37:39
Documents
2
Period of Report
2018-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4068
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4184
  Complete submission text file 0000899243-18-029668.txt   9649
Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Issuer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UROVANT SCIENCES, INC. 5151 CALIFORNIA AVENUE, SUITE 250 IRVINE CA 92617
Business Address
Kurstjens Sef (Reporting) CIK: 0001748068 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 181201835